Nonsense! Iclusig is a highly effective drug, engineered to prevent mutations, and docs are learning how to use it with maximum benefit for patients. This is normal! This is the process of introducing a new drug for a very difficult cancer. Doctors understand this, patients do, and even some investors do.
Any "analyst" worth a little more than a bucket of warm spittle, fully understands this fact (I exclude FeuerStorm and Creamer, they're worth substantially less).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.